BIOLOGIC/DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD)
Overview
Simponi Aria is approved by the Food and Drug Administration (FDA) to treat adults with active ankylosing spondylitis. Simponi Aria is also referred to by its drug name, Golimumab. Golimumab is also sold under the brand name Simponi, which has a different method of delivery.
Simponi Aria is an immunomodulator, or in other words, a drug that modulates the immune system. Specifically, Simponi Aria is considered a biologic disease-modifying antirheumatic drug (DMARD). Simponi Aria is a genetically engineered antibody, or protein used by the immune system to identify and neutralize substances. Simponi Aria is believed to work by inhibiting tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks. ... read more
We never share your personal information with anyone.